ライフサイエンスコーパス: marijuana use

1 tional states that may legalize recreational marijuana use.

2 the short-term and long-term consequences of marijuana use.

3 mplex neuroadaptive processes in response to marijuana use.

4 rug availability in the neighborhood promote marijuana use.

5 epression, smoking exposure, and alcohol and marijuana use.

6 onsumption, and 3.2% reported an increase in marijuana use.

7 e cocaine than were those with no history of marijuana use.

8 nterval, 2.4 to 9.5) in the 60 minutes after marijuana use.

9 , race, income, smoking, X-ray exposure, and marijuana use.

10 adverse cardiovascular disease outcomes and marijuana use.

11 the association between vicarious racism and marijuana use.

12 r GAD were vaccinations being up to date and marijuana use.

13 on Examination Survey based on self-reported marijuana use.

14 d unexposed donors were those with no recent marijuana use.

15 reported methylation markers associated with marijuana use.

16 nd rate of marijuana use, and perceptions of marijuana use.

17 eased following legalization of recreational marijuana use.

18 ic variables, disease severity, and previous marijuana use.

19 eating disorders, overweight or obesity and marijuana use.

20 red questionnaires that include questions on marijuana use.

21 n increase in the odds ratios of engaging in marijuana use (1.09 [95% CI, 1.04-1.14]), smoking (1.07

22 r age-related increase in the probability of marijuana use (10.46%, 23.17%, and 31.19% for 8th, 10th,

23 lower among participants reporting frequent marijuana use ( 6 times per month), relative to those re

24 Few individuals seeking treatment for marijuana use achieve sustained abstinence.

25 loyment outcomes may be poorer among regular marijuana-using adolescents.

26 changes in the rates of solitary alcohol and marijuana use among 12th grade students between 1976 and

27 ences were found in perceived harmfulness or marijuana use among 12th graders in Washington or for an

28 on models to distinguish temporal effects of marijuana use among 8th, 10th, and 12th graders from 28

29 A steady increase in marijuana use among adolescents during the latter years

30 relates of Delta8-THC use and comparisons to marijuana use among adolescents in the US are lacking.

31 Despite widespread marijuana use among adolescents, accurate information on

32 ho are in a position to identify problematic marijuana use among adolescents.

33 active cancer, with a concurrent increase in marijuana use among cancer survivors possibly associated

34 These patterns of increasing marijuana use among pregnant and postpartum people livin

35 cigarette smoking, alcohol consumption, and marijuana use among residents of Manhattan, New York Cit

36 d (FDR P <= 0.05) with recent and cumulative marijuana use and 132 and 16 methylation markers at Y20

37 me studies have found an association between marijuana use and adverse neonatal outcomes, results hav

38 ing number of states legalizing recreational marijuana use and authorizing medical marijuana programs

39 there was no significant association between marijuana use and blood CRP level among the PLWH.

40 In summary, YMSM had markedly elevated marijuana use and blood CRP levels.

41 The relationship between marijuana use and cardiovascular health remains uncertai

42 The associations between increases in marijuana use and decreases in perceiving great risk of

43 he association between recent and cumulative marijuana use and DNA methylation levels.

44 Past-year marijuana use and DSM-IV marijuana use disorder (abuse o

45 d to evaluate the relationship between donor marijuana use and each outcome.

46 -reported adolescent alcohol, cigarette, and marijuana use and early onset (before 14 years of age) o

47 adult recreational and prescription drug and marijuana use and experience of sexual violence, feminin

48 Lifetime histories of marijuana use and exposure to known OSCC risk factors we

49 Associations between heavy marijuana use and HIV disease markers or white blood cel

50 compared changes in perceived harmfulness of marijuana use and in past-month marijuana use in Washing

51 y found no association between self-reported marijuana use and increased burden of traditional ASCVD

52 , we aim to examine the relationship between marijuana use and inflammation among this high-risk coho

53 Marijuana use and legalization are a pressing issue for

54 Recent increases in marijuana use and legalization without adequate knowledg

55 known about whether the prevalence rates of marijuana use and marijuana use disorders have changed i

56 use disorders in the late 20s, as did early marijuana use and other illicit drug use.

57 Changes in marijuana use and risk perception generally began in 200

58 vide data examining the relationship between marijuana use and semen quality from young men recruited

59 r variables, there is no association between marijuana use and standard volumetric or shape measureme

60 itional insight into the association between marijuana use and the epigenome.

61 ical marijuana laws could contribute to both marijuana use and the passage of medical marijuana laws,

62 Thus, understanding trends of marijuana use and use disorders and examining factors th

63 each survey year, we estimated prevalence of marijuana use and use disorders, initiation of marijuana

64 ate legalization of medical and recreational marijuana use and use of marijuana by adolescents.

65 recent and/or cumulative history of regular marijuana use and whether these effects were sustained f

66 changes, specifically as alcohol abstinence, marijuana use, and co-use increase.

67 perception of state legalisation of medical marijuana use, and mean number of days of marijuana use

68 , history of glaucoma, knowledge and rate of marijuana use, and perceptions of marijuana use.

69 imary outcomes were past 30-day alcohol use, marijuana use, and prescription opioid misuse.

70 Parental marijuana use (aOR, 1.84; 95% CI, 1.13-2.99), parent-ado

71 smoking (aOR, 2.30; 95% CI, 1.60-3.29), and marijuana use (aOR, 3.78; 95% CI, 2.38-6.01).

72 s sensitivity analyses, including redefining marijuana use as any use in the previous year or frequen

73 n structures suggested to be associated with marijuana use, as follows: the nucleus accumbens, amygda

74 ere associated with changes in prevalence of marijuana use, as seen in the lower prevalence of mariju

75 ed variations of drug, alcohol, tobacco, and marijuana use, as well as school, prevention, and effect

76 This study examined the relationship between marijuana use, ASCVD risk factors, and cardiometabolic r

77 education >12 years, and 20% reported heavy marijuana use at >/=50% of biannual visits during follow

78 ts indicated that perceptions of legality of marijuana use (beta, 0.378; 95% CI, 0.205 to 0.444; P <

79 tract initially increased following regular marijuana use but decreased with protracted regular use.

80 t this may soon change; not due to decreased marijuana use, but to an amendment in marijuana's illega

81 Marijuana use by teenagers often predates the use of har

82 The second was whether the risk of marijuana use changed after passage of medical marijuana

83 Trends in adolescent marijuana use changed significantly during times of econ

84 stic regression provided useful estimates of marijuana use clustering and can be used to estimate clu

85 included past-year abstinence, alcohol use, marijuana use, co-use, alcohol use disorder, marijuana u

86 fter marijuana use is common among underage, marijuana-using college students.

87 Frequency of heavy drinking, marijuana use, daily cigarette smoking, and other substa

88 rijuana use and use disorders, initiation of marijuana use, daily or near daily use, perception of gr

89 ders in Washington, perceived harmfulness of marijuana use decreased and marijuana use increased foll

90 g eighth and 10th graders, respectively, and marijuana use decreased by 1.3% and 0.9% over the same p

91 Past-year marijuana use and DSM-IV marijuana use disorder (abuse or dependence).

92 met criteria for alcohol use disorder and/or marijuana use disorder accounted for 82.9% of young adul

93 However, the prevalence of marijuana use disorder among marijuana users decreased s

94 hol and marijuana, alcohol use disorder, and marijuana use disorder among US young adults is limited.

95 w exceptions, increases in the prevalence of marijuana use disorder between 2001-2002 and 2012-2013 w

96 Because the risk for marijuana use disorder did not increase among users, the

97 95% CI, 0.40%-0.59%) without an increase in marijuana use disorder for all young adults.

98 use, more adults in the United States had a marijuana use disorder in 2001-2002 than in 1991-1992.

99 nearly 3 of 10 marijuana users manifested a marijuana use disorder in 2012-2013.

100 e among users, the increase in prevalence of marijuana use disorder is owing to an increase in preval

101 polysubstance use, alcohol use disorder, and marijuana use disorder may provide valuable opportunitie

102 of those with both alcohol use disorder and marijuana use disorder reported past-year prescription d

103 as lifetime incidence of comorbid cocaine or marijuana use disorder underlie differential patterns of

104 The past-year prevalence of DSM-IV marijuana use disorder was 1.5% (0.08) in 2001-2002 and

105 marijuana use, co-use, alcohol use disorder, marijuana use disorder, prescription drug use, prescript

106 ce, either alone or with comorbid cocaine or marijuana use disorder.

107 Further, marijuana use disorders among marijuana users significan

108 of Mental Disorders, Fourth Edition (DSM-IV) marijuana use disorders and how prevalence has changed i

109 Among illicit substance use disorders, marijuana use disorders are the most prevalent in the po

110 2012-2013, and there was a large increase in marijuana use disorders during that time.

111 er the prevalence rates of marijuana use and marijuana use disorders have changed in the 21st century

112 However, marijuana use disorders in adults remained stable at abo

113 The study of marijuana use disorders is urgently needed because of in

114 Increases in the prevalence of marijuana use disorders were most notable among young bl

115 ugh it also may detect tobacco, alcohol, and marijuana use disorders, further refinement is needed be

116 Men who reported daily marijuana use displayed significant lower sperm concentr

117 organs from donors with a history of recent marijuana use do not pose significant infectious risks i

118 se cognitive deficits indicates that chronic marijuana use does not alter cortical networks, or that

119 ed with a 2% increased risk of riding with a marijuana-using driver (95% CI, 1.01-1.03).

120 f female students rode as a passenger with a marijuana-using driver (P = .21).

121 y driving after marijuana use, riding with a marijuana-using driver, driving after alcohol use, and r

122 Regular marijuana use during adolescence, but not adulthood, may

123 ients should be specifically proscribed from marijuana use during periods of high steroid administrat

124 ple living with HIV remained stable, whereas marijuana use during pregnancy and postpartum increased

125 Between 2007 and 2019, marijuana use during pregnancy increased from 7.1% to 11

126 uana use, as seen in the lower prevalence of marijuana use each year during 2006-14 than in 2002 when

127 th graders: % [SD], -9.0 [3.8]; P = .02) and marijuana use (eighth graders: % [SD], 5.0 [1.9]; P = .0

128 ed whether adolescents who engage in regular marijuana use exhibit a systematic increase in subclinic

129 rceived harmfulness or past-month adolescent marijuana use following legalization.

130 be particularly relevant in states in which marijuana use for glaucoma is legal, as in the case of t

131 As more states approve marijuana use for medical indications, physicians will b

132 pact of vicarious racism was related to more marijuana use for those lower on ethnic identity, wherea

133 Four of the 5 trials assessing self-reported marijuana use found statistically significant difference

134 There was an annual increase in marijuana use from 2002 to 2018 (college: 0.46%; 95% CI,

135 and concurrent cigarette use, the effect of marijuana use from time 2 to time 3 remained significant

136 examination and used to estimate cumulative marijuana use from Y0 to Y15 and Y20.

137 onsumed licit drugs and then transitioned to marijuana use (gateway sequence) (N=97), and boys who us

138 Perceived harmfulness of marijuana use (great or moderate risk to health from smo

139 e), heavy alcohol use (>4 drinks/day), heavy marijuana use (>21 times of marijuana use/year), and rec

140 arijuana for medical purposes and adolescent marijuana use has been controversial.

141 d gastrointestinal associations with regular marijuana use have also been established.

142 Research on regular marijuana use highlights a unique susceptibility of the

143 rmly established causality, onset of regular marijuana use in adolescence is associated with later de

144 king in adolescents aged 12 to 17 years, non-marijuana use in adolescents aged 12 to 17 years, high s

145 severity of glaucoma, prior knowledge about marijuana use in glaucoma, past marijuana use, perceptio

146 seases associated with recent and cumulative marijuana use in middle-aged adults, providing additiona

147 rrent practice patterns and attitudes toward marijuana use in patients with advanced heart failure be

148 However, the risk of marijuana use in states before passing medical marijuana

149 Marijuana use in the age group prone to coronary artery

150 With rising rates of marijuana use in the general population and an increasin

151 a withdrawal symptoms, yet does not decrease marijuana use in the laboratory or clinic.

152 ary outcome was self-reported Delta8-THC and marijuana use in the past 12 months (any vs no use and n

153 The primary outcome of this analysis was any marijuana use in the previous 30 days.

154 al marijuana use, and mean number of days of marijuana use in the previous year.

155 adients, and structural breaks in adolescent marijuana use in the United States from 1991 to 2018, we

156 With the increasing prevalence of marijuana use in the US, many deceased organ donors have

157 half (43.8%) of all patients reported weekly marijuana use in the year following treatment (dropping

158 er states that did not legalize recreational marijuana use in this period.

159 dical community and legislative groups about marijuana use in transplant candidates is needed to ensu

160 t for all but x, is largest for: 1) paternal marijuana use in transposition of great arteries with in

161 ion between the legalization of recreational marijuana use in Washington and Colorado in 2012 and the

162 rmfulness of marijuana use and in past-month marijuana use in Washington and Colorado prior to recrea

163 which exposed donors were those with recent marijuana use (in the prior 12 months) and unexposed don

164 eighth and 10th graders, respectively, while marijuana use increased 2.0% and 4.1% from 2010-2012 to

165 Postpartum concomitant alcohol and marijuana use increased by 10% (95% CI, 5%-15%) per year

166 The adjusted mean risk of marijuana use increased by 7% (95% CI, 3%-10%) per year

167 d harmfulness of marijuana use decreased and marijuana use increased following legalization of recrea

168 cohol and marijuana (10.0%) use were common; marijuana use increased from 10.2% to 23.7% from 2007 to

169 Marijuana use increased from 10.4% (95% CI 9.97-10.82) t

170 Prevalence and frequency of marijuana use increased in adults in the USA starting in

171 Driving after marijuana use increases the risk of a motor vehicle cras

172 Heavy marijuana use is a risk factor for CV disease in HIV-inf

173 for recreational use on rates of adolescent marijuana use is a topic of considerable debate.

174 The findings of this study indicate that marijuana use is associated with decreased neural respon

175 Heavy marijuana use is associated with residual neuropsycholog

176 ased case-control study to determine whether marijuana use is associated with the development of oral

177 Recent research has suggested that marijuana use is associated with volumetric and shape di

178 Driving and riding after marijuana use is common among underage, marijuana-using

179 Our findings are of public interest as marijuana use is common and may be contributing to recen

180 Importance: Medicinal marijuana use is currently legal in 23 states and the Di

181 hether the transition from licit drug use to marijuana use is determined by particular risk factors,

182 Screening for marijuana use is encouraged, especially in young patient

183 Marijuana use is increasing as more states are legalizin

184 Although states where marijuana use is legal have higher rates of use than non

185 begins in adolescence, and heavy adolescent marijuana use is often associated with impaired cognitiv

186 Marijuana use is prevalent among persons infected with h

187 A common misperception among youth is that marijuana use is without harm.

188 these trends (eg, perceptions of harms from marijuana use) is essential.

189 coma, past marijuana use, perceptions toward marijuana use (legality, systemic adverse effects, safet

190 Over time, marijuana use may alter anticipatory reward processing i

191 Marijuana use may alter ventral striatal response to rew

192 based case-control study have suggested that marijuana use may be a risk factor for squamous cell hea

193 However, adolescent marijuana use may have measurable, durable, and potentia

194 These results suggest that regular marijuana use may significantly increase the risk that a

195 The prevalence of marijuana use more than doubled between 2001-2002 and 20

196 e the stability in the overall prevalence of marijuana use, more adults in the United States had a ma

197 ), cocaine use (n=60), heroin smoking (n=6), marijuana use (n=79), oral narcotic abuse (n=20), and in

198 se (odds ratio, 4.0; 95% CI, 3.6-4.4), heavy marijuana use (odds ratio, 3.5; 95% CI, 3.2-3.7), and re

199 Questions surrounding the effects of chronic marijuana use on brain structure continue to increase.

200 Effects of marijuana use on cardiovascular (CV) events and other en

201 some studies showing detrimental effects of marijuana use on cognitive functioning and others showin

202 ion in multiple jurisdictions, the effect of marijuana use on future risk of psychiatric disorders, a

203 influence of perceptions of the legality of marijuana use on intentions to use this substance as a t

204 to date, little data exist on the impact of marijuana use on male fertility.

205 is uncertain, further study on the impact of marijuana use on male reproductive health is warranted a

206 search is needed to determine the effects of marijuana use on neural function involved in reward resp

207 viders regarding the negative association of marijuana use on semen quality.

208 The effect of prior regular marijuana use on subsequent subclinical psychotic sympto

209 uding depression; anxiety; conduct problems; marijuana use; optimism; not in education, employment, o

210 ars vs none; OR, 9.2; 95% CI, 1.4-59.4), and marijuana use (OR, 4.0; 95% CI, 1.3-12.4).

211 ette use (P<.001), alcohol use (P<.001), and marijuana use (P<.001).

212 lth from smoking marijuana occasionally) and marijuana use (past 30 days).

213 l states have passed legislation prohibiting marijuana-using patients from being denied transplant li

214 espondents from states with laws prohibiting marijuana-using patients from being denied transplant li

215 nied transplant listing reported denying all marijuana-using patients or mandating abstinence before

216 nth and lifetime diagnoses, the mean days of marijuana use per year were 225.3 (SE=5.7) and 274.2 (SE

217 ng states that did not legalize recreational marijuana use, perceived harmfulness decreased by 4.9% a

218 wledge about marijuana use in glaucoma, past marijuana use, perceptions toward marijuana use (legalit

219 zes cardiovascular considerations related to marijuana use, pharmacological interactions, and future

220 lth care and mental health care, alcohol and marijuana use, physical fights, school absenteeism, and

221 gh school heavy drinking, cigarette smoking, marijuana use, poly-prescription drug misuse, white race

222 Delta8-THC and marijuana use prevalence did not differ by sex or parent

223 many deceased organ donors have a history of marijuana use, raising concerns about infectious risks t

224 luations of the health consequences of heavy marijuana use; recommends against the use of smoked mari

225 epigenetic factors and recent and cumulative marijuana use remain limited.

226 g the adult US population, the prevalence of marijuana use remained stable at about 4.0% over the pas

227 disorders were found to have higher rates of marijuana use, repeat ED visits and/or hospital admissio

228 Self-reported past-28-day driving after marijuana use, riding with a marijuana-using driver, dri

229 Long-term heavy marijuana use showed no significant associations with vi

230 Among marijuana-using students, 43.9% of male and 8.7% of fema

231 Self-reported frequency of marijuana use, subclinical psychotic symptoms, and sever

232 be an increase in health problems related to marijuana use, such as dependence/addiction, psychosis,

233 sitively correlated with problems related to marijuana use, such that greater BOLD activation was ass

234 sence of increased frequency and quantity of marijuana use, suggesting that the concomitant increase

235 nly delinquency was more strongly related to marijuana use than licit drug use.

236 differential effects of initial and chronic marijuana use that may reflect complex neuroadaptive pro

237 With very heavy marijuana use, the net association with FEV(1) was not s

238 each year adolescent boys engaged in regular marijuana use, their expected level of subsequent subcli

239 erval 1.22-1.42) for the lifetime history of marijuana use to 2.0 (95% confidence interval 1.6-2.6) f

240 of the likelihood of adverse consequences of marijuana use to policy makers, professionals, and the p

241 Furthermore, marijuana-using twins failed to show significantly great

242 Risk of adolescent marijuana use varied by sex, racial group, family status

243 The past-year prevalence of marijuana use was 4.1% (SE, 0.15) in 2001-2002 and 9.5%

244 Self-report of marijuana use was assessed through audio computer-assist

245 Greater marijuana use was associated with later blunted activati

246 Frequent marijuana use was associated with lower inflammation amo

247 ith recreational legalization, but increased marijuana use was associated with medical marijuana lega

248 The first was whether marijuana use was higher overall in states that ever pas

249 Marijuana use was more prevalent in states that passed a

250 Occasional and low cumulative marijuana use was not associated with adverse effects on

251 Recent marijuana use was not associated with donor culture posi

252 Marijuana use was not associated with OSCC risk in this

253 Marijuana use was self-reported at the time of each cogn

254 ze brain alterations associated with chronic marijuana use, we measured gray matter (GM) volume via s

255 dds ratios for associations with features of marijuana use were adjusted for sex, education, birth ye

256 Corresponding risks associated with current marijuana use were BMI <20, OR = 2.05 (95% CI: 0.89, 4.7

257 Sixty-three healthy men with a history of marijuana use were randomly assigned to receive oral SR1

258 otal number of sexual partners, and lifetime marijuana use, whereas an increased risk was associated

259 neuroadaptive state in the setting of active marijuana use, while the long-term chronic effect of mar

260 ent study was to examine the associations of marijuana use with changes in intellectual performance i

261 sed the association of cigarette smoking and marijuana use with functional ovarian cyst risk by using

262 models were used to test the association of marijuana use with neural response in the NAcc to reward

263 hors test for and estimate the clustering of marijuana use within United States neighborhoods, making

264 inks/day), heavy marijuana use (>21 times of marijuana use/year), and recreational drug use.